CHAPTER 1 INTRODUCTION
1.1 Report description
1.2 Key benefits
1.3 Key market segments
1.4 Research methodology
1.4.1 Secondary research
1.4.2 Primary research
1.4.3 Analyst tools and models
CHAPTER 2 EXECUTIVE SUMMARY
2.1 CXO perspective
CHAPTER 3 MARKET OVERVIEW
3.1 Market definition and scope
3.2 Key findings
3.2.1 Top investment pockets
3.2.2 Top winning strategies
3.3 Porters five forces analysis
3.3.1 Bargaining power of suppliers
3.3.2 Bargaining power of buyers
3.3.3 Threat of new entrants
3.3.4 Threat of substitutes
3.3.5 High intensity of rivalry
3.4 Regulatory scenario
3.4.1 Government regulations across countries
3.4.2 Womens preventive services guideline
3.4.3 FDA-approved contraceptives method
3.4.4 The Affordable care act contraceptive coverage and advantages
3.5 Market dynamics
3.5.1 Drivers
3.5.1.1 Rise in need to reduce unwanted pregnancy
3.5.1.2 Increasing awareness for contraceptives worldwide
3.5.1.3 Rising usage of oral contraceptives as preferred method to avoid unplanned pregnancy
3.5.1.4 Technological advancements in contraceptive methods
3.5.1.5 Upsurge in government and NGO initiatives promoting contraceptives
3.5.1.6 Increasing awareness about STDs
3.5.2 Restraints
3.5.2.1 Health risks associated with the use of contraceptive methods
3.5.2.2 Lack of social acceptance
3.5.3 Opportunities
3.5.3.1 Presence of large unmet contraceptive needs in emerging Asian and African Economies
CHAPTER 4 WORLD CONTRACEPTIVES MARKET, BY PRODUCT, 2014-2022
4.1 Overview
4.1.1 Market size and forecast
4.2 Drugs
4.2.1 Key market trends
4.2.2 Key growth factors and opportunities
4.2.3 Market size and forecast
4.2.4 Oral contraceptive or pills
4.2.4.1 Market size and forecast
4.2.5 Injectable contraceptives
4.2.5.1 Market size and forecast
4.2.6 Topical contraceptives
4.2.6.1 Market size and forecast
4.3 Contraceptive devices
4.3.1 Key market trends
4.3.2 Key growth factors and opportunities
4.3.3 Market size and forecast
4.3.4 Condoms
4.3.4.1 Market size and forecast
4.3.4.2 Female condoms
4.3.4.2.1 MARKET SIZE AND FORECAST
4.3.4.3 Male condoms
4.3.4.3.1 MARKET SIZE AND FORECAST
4.3.5 Intrauterine devices (IUD)
4.3.5.1 Market size and forecast
4.3.5.2 Hormonal IUDs
4.3.5.2.1 MARKET SIZE AND FORECAST
4.3.5.3 Copper IUDs
4.3.5.3.1 MARKET SIZE AND FORECAST
4.3.6 Contraceptive diaphragms
4.3.6.1 Market size and forecast
4.3.7 Contraceptive sponges
4.3.7.1 Market size and forecast
4.3.8 Contraceptive patches
4.3.8.1 Market size and forecast
4.3.9 Sub-dermal contraceptive implants
4.3.9.1 Market size and forecast
4.3.10 Contraceptive vaginal rings
4.3.10.1 Market size and forecast
4.3.11 Others
4.3.11.1 Market size and forecast
CHAPTER 5 WORLD CONTRACEPTIVES MARKET, BY AGE GROUP
5.1 Overview
5.1.1 Market size and forecast
5.2 15-24 years
5.2.1 Market size and forecast
5.3 25-34 years
5.3.1 Market size and forecast
5.4 35-44 years
5.4.1 Market size and forecast
5.5 Above 44 years
5.5.1 Market size and forecast
CHAPTER 6 WORLD CONTRACEPTIVES MARKET, BY EDUCATION
6.1 Overview
6.1.1 Market size and forecast
6.2 Less than high school
6.2.1 Market size and forecast
6.3 High school graduate
6.3.1 Market size and forecast
6.4 College graduate
6.4.1 Market size and forecast
6.5 Other college degrees
6.5.1 Market size and forecast
CHAPTER 7 WORLD CONTRACEPTIVES MARKET, BY END USER
7.1 Overview
7.1.1 Market size and forecast
7.2 Household
7.2.1 Market size and forecast
7.3 Hospitals
7.3.1 Market size and forecast
7.4 Clinics
7.4.1 Market size and forecast
CHAPTER 8 CONTRACEPTIVES MARKET, BY GEOGRAPHY, 2014-2022
8.1 Overview
8.1.1 Market size and forecast
8.2 North America
8.2.1 Key market trends
8.2.2 Key growth factors and opportunities
8.2.3 Market size and forecast
8.2.3.1 U.S. contraceptives market
8.2.3.2 Canada contraceptives market
8.2.3.3 Mexico contraceptives market
8.3 Europe
8.3.1 Key market trends
8.3.2 Key growth factors and opportunities
8.3.3 Market size and forecast
8.3.3.1 Germany contraceptives market
8.3.3.2 France contraceptives market
8.3.3.3 U.K. contraceptives market
8.3.3.4 Rest of Europe contraceptives market
8.4 Asia-Pacific
8.4.1 Key market trends
8.4.2 Key growth factors and opportunities
8.4.3 Market size and forecast
8.4.3.1 Japan contraceptives market
8.4.3.2 China contraceptives market
8.4.3.3 Australia contraceptives market
8.4.3.4 India contraceptives market
8.4.3.5 Rest of Asia Pacific contraceptives market
8.5 LAMEA
8.5.1 Key market trends
8.5.2 Key growth factors and opportunities
8.5.3 Market size and forecast
8.5.3.1 Brazil contraceptives market
8.5.3.2 Turkey contraceptives market
8.5.3.3 Venezuela contraceptives market
8.5.3.4 South Africa contraceptives market
8.5.3.5 Rest of LAMEA contraceptives market
CHAPTER 9 COMPANY PROFILES
9.1 Mylan N.V.
9.1.1 Company overview
9.1.2 Operating business segments
9.1.3 Business performance
9.1.4 Key strategic moves & developments
9.2 Ansell Limited
9.2.1 Company overview
9.2.2 Operating business segments
9.2.3 Business performance
9.2.4 Key strategic moves & developments
9.3 Bayer AG
9.3.1 Company overview
9.3.2 Operating business segments
9.3.3 Business performance
9.3.4 Key strategic moves & developments
9.4 Church & Dwight Co., Inc.
9.4.1 Company overview
9.4.2 Operating business segments
9.4.3 Business performance
9.5 Merck & Co., Inc.
9.5.1 Company overview
9.5.2 Operating business segments
9.5.3 Business performance
9.6 Pfizer Inc.
9.6.1 Company overview
9.6.2 Operating business segments
9.6.3 Business performance
9.6.4 Key strategic moves & developments
9.7 Teva Pharmaceutical Industries Limited
9.7.1 Company overview
9.7.2 Operating business segments
9.7.3 Business performance
9.7.4 Key strategic moves & developments
9.8 The Cooper Companies, Inc.
9.8.1 Company overview
9.8.2 Operating business segments
9.8.3 Business performance
9.8.4 Key strategic moves & developments
9.9 The Female Health Company
9.9.1 Company overview
9.9.2 Operating business segments
9.9.3 Business performance
9.9.4 Key strategic moves & developments
9.10 Mayer Laboratories, Inc.
9.10.1 Company overview
